Marte C. Liefaard
-
- Cancer Genomics and Diagnostics 4
-
- CAR-T cell therapy research 5
- HER2/EGFR in Cancer Research 5
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Biosimilars and Bioanalytical Methods 3
-
- AI in cancer detection 2
- Co-authors
- Esther H. LipsJelle WesselingMaarten AltelaarWei WuJessica C. Kiefte–de JongAbbas DehghanSymen LigthartAndré G. Uitterlinden
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Marte C. Liefaard
19 papers receiving 334 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 131
- Immunology and Allergy 27
- Pathology and Forensic Medicine 58
- Oncology 87
- Health Informatics 4
Countries citing papers authored by Marte C. Liefaard
This map shows the geographic impact of Marte C. Liefaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marte C. Liefaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marte C. Liefaard more than expected).
Fields of papers citing papers by Marte C. Liefaard
This network shows the impact of papers produced by Marte C. Liefaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marte C. Liefaard. The network helps show where Marte C. Liefaard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marte C. Liefaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2021 | 24 | |
| 18 | 2019 | 173 | |
| 19 | 2019 | 7 | |
| 20 | 2015 | 70 |
About Marte C. Liefaard
Marte C. Liefaard is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 20 papers that have together received 338 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Biosimilars and Bioanalytical Methods (3 papers), AI in cancer detection (2 papers), Cancer Cells and Metastasis (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Cancer Research (131 citations), Immunology and Allergy (27 citations) and Pathology and Forensic Medicine (58 citations). Marte C. Liefaard has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Esther H. Lips, Jelle Wesseling, Maarten Altelaar, Wei Wu, Jessica C. Kiefte–de Jong, Abbas Dehghan, Symen Ligthart, André G. Uitterlinden, Anna Vitezova and Albert Hofman. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.